PetMed Express, Inc. (PETS)
2.98
+1.21
(+68.36%)
USD |
NASDAQ |
Dec 11, 16:00
3.02
+0.04
(+1.34%)
Pre-Market: 08:47
PetMed Express EPS Diluted (Quarterly): -0.5637 for March 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CDT Equity, Inc. | -13.16 |
| LENZ Therapeutics, Inc. | -0.5851 |
| Liminatus Pharma, Inc. | -0.0675 |
| Oruka Therapeutics, Inc. | -0.6871 |
| Maze Therapeutics, Inc. | -0.6258 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.64M |
| Revenue (Quarterly) | 46.47M |
| Total Expenses (Quarterly) | 58.11M |
| Enterprise Value | 8.912M |
| Gross Profit Margin (Quarterly) | 36.31% |
| Profit Margin (Quarterly) | -25.06% |
| Earnings Yield | -10.32% |
| Operating Earnings Yield | 1.92% |
| Normalized Earnings Yield | -7.228 |